ClinicalTrials.gg
Not yet recruitingNCT05759663MIRRADRCTUpdated Jan 3, 2025

MIRRAD Versus Plication of Entire Diastasis Trial

An interventional study of MIRRAD and Plication of the entire diastasis arm in Muscle Diastasis, sponsored by Karolinska Institutet. Not yet recruiting at 2 sites in Sweden. Open to female participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2025-01-03.

Sponsored by Karolinska Institutet · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
Female
01

Study summary

Background Postpartum diastasis of the rectus abdominis muscles (DRAM) has gained increasing attention as a condition that may affect abdominal trunk function but that may be alleviated by surgery. Most techniques for surgical reconstruction of DRAM are, however, associated with high costs, postoperative pain and risk of surgical complications. The aim of the present study is to evaluate a Minimal Incision Repair of Rectus Abdominis Diastasis (MIRRAD) in a randomized controlled open label trial. Altogether 120 women will be included.

Population Postpartum women with DRAM of at least 2 cm.

Intervention Plication of Linea alba through a 3-5 centimeter long incision at the level of the umbilicus

Control Plication of the entire Linea alba through a low transverse incision.

Outcome Primary outcome: Abdominal function rated with the Disability Rating Index Secondary outcomes: Operative time, postoperative stay, surgical complications, sick leave, persisting pain orated with the Ventral Pain Hernia Questionnaire, cosmetic outcome rated with BODY-Q

Follow-up Follow-up one month and one year after surgery

Significance If the study shows that MIRRAD is equally effective as plication of the entire Linea alba one year after surgery, it may be introduced as a standard technique for DRAM. If it is not as effective, it may still be an alternative with advantages in terms of cost benefit and the possibility to perform it as a daycare procedure.

Read the detailed description

Background

Diastasis of the rectus abdominis muscles (DRAM) is a well-known phenomenon that until recently has not attracted much attention. It may either develop in high age, often in combination with truncal obesity, or as the result of one or more pregnancies. Several studies, have, however, shown that post-partum DRAM may cause impaired abdominal trunk function, often combined with pelvic floor dysfunction and back pain. Studies have also shown that these problems can be reduced with surgery aimed at restoring the integrity of the Linea alba [1-3] The favorable outcomes in well-selected samples of post-partum women [4] have resulted in a widespread demand for broadened indications and that such surgery should be offered routinely to all post-partum women with abdominal trunk dysfunction. However, concerns have been raised regarding the costs and potential hazards from such a procedure for a condition that is associated with abdominal function impairment but no potential serious morbidity.

The surgical techniques for restoring abdominal wall function in women with postpartum DRAM are mainly based on experience from ventral hernia surgery. The aim of ventral hernia surgery is ultimately to reduce the hernia sac to the abdominal cavity and closing the hernia defect in a way that the risk of recurrences is minimized. This may either be carried with an open or endoscopic technique, and with or without mesh reinforcement. Most studies on DRAM surgery are thus focused on strengthening the entire Linea alba and minimizing the risk for recurrence. In case of restoring the abdominal trunk function in DRAM, however, the aim should rather be to prevent the rectus muscles from separating during tension and thereby leaving room for the midline bulge of the abdominal trunk and loss of tonus in the abdominal wall.

Surgery for DRAM should thus aimed at being cost-effective and atraumatic enough to be offered for a very large number of women in need of treatment for DRAM as well as to be safe enough to ensure that postoperative complications and early recurrences are not seen. For that purpose, we intend to evaluate a surgical technique that limits the surgical trauma and could be carried out in a large scale without need of great resources.

Study design

The study will be conducted as an open label randomized controlled trial where an established and evaluated technique, i.e., plication of the dilated part of Linea alba with open technique through a low transverse skin incision will be compared with MIRRAD. Before inclusion the woman should have undergone an organized training program without satisfying result. After consent has been given, the patient is randomized between MIRRAD or plication of the entire DRAM. Prior to surgery the patient undergoes examination by a physiotherapist and the Abdominal Trunk Function Protocol is completed. Regardless of allocation, the procedure is carried out under general anesthesia.

MIRRAD arm A 3 cm vertical incision is made above the umbilicus. The umbilicus is de-attached from the Linea alba so that Linea alba 5-7 cm above and 3-5cm below the umbilicus is exposed. The abdominal rectus muscle diastasis is then plicated with double layer barbed suture. The first suture line is over and over continuous suture and the second suture line continuous suture line. The umbilicus is then re-attached with a single stich . The skin is closed with continuous intradermal sutures.

Plication of the entire diastasis arm A low transverse incision is made and the subcutaneous tissue along the Linea alba dissected. If there is any hernia present in the Linea alba, it is invaginated in a plicated suture line. The entire DRAM along the Linea alba is plicated with continuous sutures. Excessive skin and subcutaneous tissue along the incision is excised and the wound closed. The subcutaneous tissue is closed with interrupted 4-0 PDS® stitches. The skin is closed with continuous intradermal sutures.

Follow-up Four hours after the procedure is completed the woman is requested to rate pain and nausea on VAS scales. All included women are invited to follow-up one month and one year after surgery. At the follow-up one month after surgery, postoperative complications, day of return to work are registered and the abdominal function is rated according to the Disability Rating Index of the Abdominal Trunk Function Protocol and persisting pain according to the Ventral Hernia Pain Questionnaire. At the one year postoperatively abdominal function is evaluated according to the Abdominal Trunk Function Protocol, persisting pain with Ventral Hernia Pain Questionnaire and cosmetic outcome with the belly contour items of the BODY-Q questionnaire

02

Conditions studied

  • Muscle Diastasis

Browse trials for

Keywords

  • Postpartum
  • Diastasis of the Rectus Abdominis Muscles
  • Surgery
03

In context

Diastasis, Muscle

7 studies on the registry are indexed under Diastasis, Muscle; 3 are open to participants now.

Browse Diastasis, Muscle studies →

Lead sponsor

Karolinska Institutet is the lead sponsor of 1,150 studies on the registry; 276 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women having undergone at least one pregnancy
  • Age 20 - 50 years
  • Minimum 2 cm diastasis of rectus abdominis muscle at the level of the umbilicus
  • \< 30
  • Treatment failure after six months of structured training

Exclusion criteria

Exclusion Criteria:

  • Nulliparous women
  • Less than one year since last pregnancy
  • Women who have not undergone structured training for at least six months
  • Previous abdominal surgery through open midline incision
  • Presence of excessive skin folds
  • Future planned pregnancies
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    MIRRAD

    A 3 cm vertical incision is made above the umbilicus. The umbilicus is de-attached from the Linea alba so that Linea alba 5-7 cm above and 3-5cm below the umbilicus is exposed. The abdominal rectus muscle diastasis is then plicated with double layer barbed suture. The first suture line is over and over continuous suture and the second suture line continuous suture line. The umbilicus is then re-attached with a single stich .

    Procedure: MIRRAD

  • Active comparator
    Plication of the entire diastasis arm

    A low transverse incision is made and the subcutaneous tissue along the Linea alba dissected. If there is any hernia present in the Linea alba, it is invaginated in a plicated suture line. The entire DRAM along the Linea alba is plicated with continuous sutures. Excessive skin and subcutaneous tissue along the incision is excised and the wound closed. The subcutaneous tissue is closed with interrupted 4-0 PDS stitches.

    Procedure: Plication of the entire diastasis arm

Interventions

  • ProcedureMIRRAD

    Repair of the diastasis with MIRRAD technique

  • ProcedurePlication of the entire diastasis arm

    Plication of the entire diastasis

06

What researchers measure

Primary outcomes

  1. Abdominal trunk function

    Abdominal function assessed with Abdominal Trunk Function Protocol one year after surgery

    Time frame: One year

Secondary outcomes

  1. Operation time

    Time required to complete the procedure

    Time frame: Two hours

  2. Postoperative pain 4 hours after surgery

    Pain rated on a VAS scale

    Time frame: Four hours

  3. Postoperative nausea 4 hours after surgery

    Nausea rated on a VAS scale

    Time frame: Four hours

  4. Time from surgery to discharge

    Time from surgery to the moment when the patient is discharged

    Time frame: Seven days

  5. Surgical complications

    Complications related to the procedure rated according to Clavien-Dindo

    Time frame: Thirty days

  6. Postoperative sick leave

    Time from surgery to full return to work

    Time frame: Thirty days

  7. Postoperative seroma

    Subcutaneous confirmed at clinical examination 30 days postoperatively

    Time frame: Thirty days

  8. Pain from abdominal wall

    Pain from abdominal wall rated with VHPQ one month and one year after surgery

    Time frame: One year

  9. Abdominal Trunk function

    Abdominal Trunk function assessed with Abdominal Trunk Function Protocol one month after surgery

    Time frame: One month

  10. Cosmetic satisfaction

    Cosmetic outcome rated with BODY-Q one year after surgery

    Time frame: One year

07

Study locations

2 sites
  • Department of Surgery, Karloskoga Hospital
    Karlskoga, 69144, Sweden
  • Stockholm South General Hospital
    Stockholm, 11883, Sweden
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Aug 2025; primary completion for Dec 2026, 16 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 26, 2023
First posted
Mar 8, 2023
StartEst.
Aug 1, 2025
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2027
Last update
Jan 3, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05759663
Collaborators
Karlskoga Hospital
Responsible party
Gabriel Sandblom (Associate Professor, Karolinska Institutet) — Principal investigator
First posted
Mar 8, 2023
Start date
Aug 1, 2025 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Jan 3, 2025

Study contacts

Gabriel Sandblom, Ass Prof
Contact
gabriel.sandblom@ki.se
+46704158218
Gabriel Sandblom, Ass prof
principal investigator · Karolinska Institutet

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion